Recombinant human CTLA-4 protein

Cat No.
ATGP3918

Size

QTY

List Price

10ug

USD 80


20ug

USD 130

50ug

USD 220

100ug

USD 250

250ug

USD 300

500ug

USD 520

1mg

USD 860

USD 0



Product Information

Product Type
Recombinant Protein
Expression System
Baculovirus
Domain
36-161aa
UniProt No.
P16410
NCBI Accession No.
NP_005205
Alternative names
CTLA4, Cytotoxic T-lymphocyte-associated protein 4, Cytotoxic T-lymphocyte-associated antigen 4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12, ATGP3334
Additional Information
ATGP3334 has been replaced with a catalog number A

Product Specification

Molecular Weight
14.6 kDa (135aa)
Concentration
0.25mg/ml (determined by absorbance at 280nm)
Formulation
Liquid in. Phosphate-Buffered Saline (pH 7.4) containing 20% glycerol
Purity
> 90% by SDS-PAGE
Bioactivity
The activity is determined by the IL-2 ELISA in a using Jurkat human acute T cell leukemia cells. The ED50 range ≤150ng/ml with Human B7-1/CD80.
Endotoxin
< 1 EU per 1ug of protein (determined by LAL method)
Tag
His-Tag
Applications
SDS-PAGE,Bioactivity
Storage
Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.

Data

SDS-PAGE

3ug by SDS-PAGE under reducing condition and visualized by coomassie blue stain. ..

Biological Activity

Human CTLA-4 inhibits Human B7-1/CD80 induced IL-2 secretion of the Jurkat human acute T cell leukemia cells. The ED50 range ≤150 ng/ml.

Note: For research use only. This product is not intended or approved for human, diagnostics or veterinary use.